(Q34477257)

2 August 2017

1 reference

title

Natural killer cells and natural killer cell activity in chronic fatigue syndrome (English)

1 reference

2 August 2017

Whiteside TL

1

1 reference

PubMed ID

9790479

2 August 2017

Friberg D

series ordinal

2

1 reference

PubMed ID

9790479

2 August 2017

language of work or name

English

0 references

publication date

1 September 1998

1 reference

American Journal of Medicine

2 August 2017

1 reference

2 August 2017

105

1 reference

2 August 2017

3A

1 reference

2 August 2017

27S-34S

1 reference

Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

Chronic fatigue syndrome: a working case definition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

Immunological abnormalities in patients with chronic fatigue syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

Lymphocyte subsets, apoptosis, and cytokines in patients with chronic fatigue syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

The role of natural killer cells in immune surveillance of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

Antitumor Functions of Natural Killer Cells and Control of Metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

Effect of rhinovirus 39 infection on cellular immune parameters in allergic and nonallergic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

Effect of influenza A virus infection on natural and adaptive cellular immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

Activation and role of natural killer cells in virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

HIV-induced cysteine deficiency and T-cell dysfunction--a rationale for treatment with N-acetylcysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

Low NK syndrome and its relationship to chronic fatigue syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

Decreased natural killer cell activity is associated with severity of chronic fatigue immune dysfunction syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

Immunologic abnormalities associated with chronic fatigue syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

Dysfunction of natural killer activity in a family with chronic fatigue syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

Changes of natural killer cells during acute psychological stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

Modulation of human natural killer cell activity by exposure to uncontrollable stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

The role of natural killer cells in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

Inflammatory infiltrates and natural killer cell presence in human brain tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

Stress, emotion, and human immune function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

Viral studies of chronic fatigue syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

Chronic fatigue syndrome: clinical condition associated with immune activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

Immunologic abnormalities in chronic fatigue syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900155-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(98)00155-7

1 reference

2 August 2017

1 reference

PubMed ID

9790479